A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III (Q5214489): Difference between revisions
From MaRDI portal
Set profile property. |
Set OpenAlex properties. |
||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2898451045 / rank | |||
Normal rank | |||
Latest revision as of 21:53, 19 March 2024
scientific article; zbMATH DE number 7165177
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III |
scientific article; zbMATH DE number 7165177 |
Statements
A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III (English)
0 references
7 February 2020
0 references
Bayesian design
0 references
clinical trial
0 references
dose finding
0 references
phase I-II clinical trial
0 references
phase III clinical trial
0 references
